Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Nanoparticles can improve skin treatments by better targeting hair follicles, but more research is needed for advancement.

Fatty acid transport protein 4 is essential for skin and hair development.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

BMP2 and BMP7 have opposite roles in feather formation.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

ADSC-CM treatment improved hair density and thickness in women with hair loss, safely and effectively.

Minoxidil boosts hair growth by targeting adenosine and possibly sulfonylurea receptor 2B.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

The document concludes that minoxidil and finasteride are proven for hair growth, herbal remedies show promise, but more research is needed to confirm their effectiveness.

Fat tissue stem cells may help increase hair growth.

Follistatin helps hair growth and cycling, while activin prevents it.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

The VVG stain effectively differentiates scar tissue from normal skin and helps classify types of permanent alopecia.

Smart biomaterials that guide tissue repair are key for future medical treatments.

Dandruff is mainly caused by a scalp reaction to yeast, can worsen hair loss, and antifungal treatments may help.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.